Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Respiratory syncytial virus

Recent news which mentions Respiratory syncytial virus

Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Tags Biotech and Pharmaceuticals Pharmaceuticals Business News
From CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
Tags Pharmaceuticals Biotech and Pharmaceuticals Business News
From CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
Tags Breaking news Respiratory syncytial virus Companies
From CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
Tags GSK plc Pfizer Inc Health care industry
From CNBC.com News
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
Tags Respiratory syncytial virus Breaking news Companies
From CNBC.com News
FDA approves Pfizer maternal RSV vaccine for infants
Tags Science US: News Health & Science
From CNBC.com News
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
Tags Biotech and Pharmaceuticals Pharmaceuticals Business News
From CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
Tags Companies Breaking news Respiratory syncytial virus
From CNBC.com News
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
Tags Companies Immunizations Social issues
From CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
Tags US: News Business Biotechnology
From CNBC.com News
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
Tags GSK plc Pfizer Inc Health care industry
From CNBC.com News
GSK says RSV vaccine for older adults provides protection over two seasons
Tags Breaking news Respiratory syncytial virus Immunizations
From CNBC.com News
Pfizer RSV vaccine for older adults is only slightly less effective after 18 months
Tags Business News Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
FDA approves Pfizer RSV vaccine for older adults
Tags Biotech and Pharmaceuticals Epidemics Disease outbreaks
From CNBC.com News
Here’s what Pfizer and Moderna say is next for their Covid vaccines
Tags BioNTech SE Business News Coronavirus
From CNBC.com News
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
Tags Respiratory syncytial virus Immunizations Social issues
From CNBC.com News
Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say
Tags Respiratory syncytial virus Companies Immunizations
From CNBC.com News
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
Tags Biotechnology Science Business News
From CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
Tags GSK plc US Top News and Analysis U/S/ Economy
From CNBC.com News
Moderna, Pfizer's new race: The RSV vaccine FDA approval process
Tags Respiratory syncytial virus CNBC Disruptor 50 Moderna Inc
From CNBC.com News
A nutritionist shares the best snacks to bring on a plane to boost your immune system
Tickers LIFE
Tags Traditional Chinese medicine Exercise Travel
From CNBC.com News
Why flu season is so bad this year
Tickers LIFE
Tags Respiratory syncytial virus Politics U/S/ Economy
From CNBC.com News
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data shows
Tags Policy US: News Business
From CNBC.com News
Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV
Tickers AZN AZNCF SNY
Tags Biotech AZN General
From Benzinga
Pfizer's RSV Vaccine Candidate Receives FDA Breakthrough Therapy Tag For Prevention of RSV In Older Adults
Tickers PFE
Tags Market News Biotech FDA
From Benzinga
Johnson & Johnson Posts Additional RSV Vaccine Data
Tickers JNJ
Tags Benzinga Health Care News
From Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
Tickers JNJ
Tags REspiratory syncytial virus General News
From Benzinga
Pfizer Starts Late-Stage Trial For RSV Vaccine Candidate In Older Patients
Tickers PFE
Tags Health Care Benzinga REspiratory syncytial virus
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.